BOFAS Membership Survey BOFAS Membership Survey Please Complete before 31st March! 11 March 2024 Have your say! First BOFAS Membership Survey: https://www.surveymonkey.com/r/3CHVDYP Read more
Get Ready for BOFAS 2024 Get Ready for BOFAS 2024 Download the App Now! 03 March 2024 This year we are all digital - download the BOFAS Conference App on the Play Store or the App Store. Read more
BOFAS 2024 Programme Now Live BOFAS 2024 Programme Now Live Registration Rates Increasing from Jan 2024 - Sign up now! 21 December 2023 Click here to see the BOFAS 2024 Programme! Read more
10Feb2026 BOFAS Principles Course Liverpool 2026 - space available 10/02/2026 - 11/02/2026 Read more These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open now. Read more
Togay Koç / 11 July 2022 / Categories: Abstracts, 2016, Podium Foot and ankle injections - are they worth it? D. Marsland, J. Grice, J. Calder Introduction: Injections are used to treat a wide variety of pathologies. Our aim was to evaluate the efficacy and safety of foot and ankle injections in our clinic. Materials and methods: We performed a retrospective review of notes and a telephone questionnaire audit into the clinical outcome of all patients who underwent an injection of the foot or ankle in a year. All procedures were performed in an out-patient setting by a consultant musculoskeletal radiologist using either ultrasound or X-ray guidance, with a minimum of two year follow-up. According to the pathology treated, the type of injection included depomedrone, hyaluronic acid and high volume saline injections. Results: Overall 410/446 (92%) patients reported a significant improvement in symptoms and 227 (62%) reported complete resolution of their pain, with 127 (28%) remaining asymptomatic at two year follow-up. The mode time of recurrence of pain was three months. 59 (13%) underwent a further injection and 102 (23%) underwent operative intervention within the follow-up period. There were no reported infections. Complications occurred in two percent of patients, including steroid flare, pain and plantar plate ruptures. Conclusion: Injections are a safe and effective option for treating a variety of foot and ankle conditions and reduce the need for surgery. They are particularly effective for the treatment of ankle soft tissue impingement. They appear ineffective in providing significant improvement in pain for longer than three months in conditions such as plantar fasciitis and hallux rigidus. Print 849 Tags: AnkleHallux RigidusPlantar Fasciitis